CEINGE - Biotecnologie Avanzate, Napoli, Italia   Report issue

Foundation Phase 4
Founded: Napoli Italy (1983)

Organization Overview

First Clinical Trial
2019
NCT04107428
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CEINGE - Biotecnologie Avanzate, Napoli, Italia

Active Ingredients

Drugs in Phase 4 Trials (1)

somatostatin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

End Stage Liver Disease (Phase 4)

Hypertension, Portal (Phase 4)

Liver Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1